“…As such, this approach has been widely applied in preclinical models and clinical trials. oHSVs armed with immunomodulators continue to be popular among oHSV laboratories, and continue to be studied in ongoing clinical and preclinical investigations of oHSV therapy (94, 96, 98–103). …”